The Southwest National Pediatric Device Consortium (SWPDC), anchored by Texas Children’s Hospital and Baylor College of Medicine and including Texas A&M University, recently received a prestigious P50 grant from the U.S. Food & Drug Administration (FDA). The five-year, $6.75 million grant will begin on Sept. 1.
The Turbomachinery Laboratory at Texas A&M University will host its 47th Turbomachinery and 34th Pump Symposia (TPS), Sept. 18-20 in Houston at the George R. Brown Convention Center. Full-day short courses will be held in conjunction with the symposia on Sept. 17.
The National Center for Therapeutics Manufacturing’s (NCTM) BioFORCE Summer Academy has just completed its seventh year, having served a grand total of 566 rising Texas high school sophomores, juniors and seniors, several dozen of whom have gone on to become Texas A&M University Aggies.
A lifesaving device more than 20 years in the making has received clearance from the U.S. Food and Drug Administration. The clearance allows a company, co-founded by Associate Department Head Dr. Duncan Maitland, to begin to market the medical device.
From June 23-30, a group of graduate students, faculty and national laboratory staff members participated in the Nuclear Facilities Experience (NFE), which took place in various locations across Japan. .
The Texas A&M University System will join a consortium of higher education institutions and state agencies that will offer expertise, research and innovations in support of the U.S. Army Futures Command (AFC) in Austin, the U.S. Army announced Friday from the Pentagon.